That is very important, because the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (longtime readers). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was an advancement nearly no one discovered. However it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this space, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown 1 biotech company). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back possibly significantly prior to going greater - tech stock. I have actually been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly informing readers. But that's not the big question any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown biotech stocks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are so many fantastic personal companies on the verge of striking the public markets And I have actually been dealing with a new way for you to invest even prior to these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to book your area for free.
Emma Walsh here, managing editor of the Diary. Routine Journal readers understand that tech isn't our typical beat (exponential tech investor). And when it comes to tech investing, we leave it to the specialists. The good news is, we have several such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing professionals we know (last week). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and predict what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential growth and developing extraordinary opportunities for investors. I want to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown market predictions. But regardless of what many readers may believe, this is a trend that's simply getting begun. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown market predictions). Losing two months of production and sales truly impacts how lots of 5G gadgets are sold in the fiscal year. When you consider all of that, selling 250 million units is amazing. More significantly, the delays brought on by the pandemic created a lots of bottled-up demand. And that need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - jeff brown top biotech 2020. Which's not my only 5G prediction When I have actually talked about 5G in the past, I've explained its three various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Stage 3, 5G services begin to be used (genetic sequencing companies jeff brown). That's when we begin to see applications working on 5G networks. Think about things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase Three by this summertime. This starts something of a virtuous cycle: The majority of people do not really appreciate the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open a suite of amazing applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be massive. Stepping far from 5G, the next essential innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a comparable idea however with our genetic code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For several years, CRISPR was primarily a niche technology that wasn't well understood. And during that time, there were truly only 3 business running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real results. We're treating illness and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole market is efficiently a greenfield opportunity.
There's space for numerous companies to exist in this space. angel investor. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software can precisely forecast the folding of a protein based solely on its amino acid series with 92. 4% precision. That is essential due to the fact that the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error process. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced using this innovation. This was among those advancements that nearly nobody noticed. But it's going to have extensive implications for treating illness. And, of course, there will be plenty of financial investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly considerably prior to going greater. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin - brownstone research. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. brownstone research stock. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date since February 2021, however we might not individually confirm this claim. Given Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like capability to choose winning innovation stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional viewpoint on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a number of his best picks in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully forecasted a few of the most significant economic events of the previous twenty years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right whenever, however Jeff Brown's accurate predictions have made him legions of devoted fans. That says a lot about his ability. The Future Report is published by Brownstone Research, a prominent monetary research publisher. Brownstone Research study uses numerous research study services with a wide range of specializations - jeff brown top biotech 2020.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - korean actress. On its website, Brownstone states its objective is to offer retail investors with professional-grade research: "For too long, the best investment research study has actually not been available to private financiers. It has been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. the legacy report predictions. The objective of Brownstone Research study is to make that kind of proprietary research study offered to any investors aiming to gain an edge in the markets. The goal is simple to deliver distinct and profitable financial investment research study found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise acts as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you understand even a little bit about the market, you understand that he has a track record as a King Midas of sorts. self-driving cars. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown thinks S.A.V. angel investor. could be "the greatest trend of the 2020s, and he's not alone. Check out these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding 2 advanced innovations: expert system and electric cars. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving cars ever. It's absolutely nothing short of the automobile market's Holy Grail. As you know, electrical vehicles and self-driving vehicle stocks have been huge this year, however the Wall Street device has approved hype without much concrete result. Despite a drastic boost in competition over the previous couple of years, Brown still believes Musk has the very best chance of putting it all together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transportation. Generally, this technology would allow you to lease out your cars and truck as an autonomous, self-driving taxi when you're not using it. You simply leave the automobile and press a button on an app that tells the automobile to "join the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the revenues. It sounds ridiculous, however it might be closed than you believe.